Clinical guidelines recommend treatment for hyperkalemia should include the administration of intravenous (IV) insulin in doses ranging from 5 to 10 units, along with 25 to 50 g of dextrose [9,10]. The gene discussed is INS; the disease is Hyperkalemia.